Literature DB >> 6644552

Pharmacokinetic study of the fate of acetaminophen and its conjugates in rats.

N Watari, M Iwai, N Kaneniwa.   

Abstract

Pharmacokinetic studies of the fate of acetaminophen and its major metabolites, acetaminophen sulfate (AS) and acetaminophen glucuronide (AG), were made in rats. The rates of conjugate formation were calculated by deconvolution. The Michaelis-Menten equation gave maximum velocity and Michaelis constant (Km) values of 4.92 mumol/min/kg and 109 microM for AS formation, and 2.76 mumol/min/kg and 915 microM for AG formation. However, AG formation showed approximately first-order behavior in the present dose range because of its large Km value. The disposition of acetaminophen could be described by a two-compartment model with simultaneous first-order and Michaelis-Menten type elimination kinetics for AS formation. Curve fitting of the data based on this model was successfully done for doses of up to 1058 mumol/kg, suggesting that sulfation proceeds without depletion of sulfate in the blood at least up to this dose. The disposition of AS could be described by a two-compartment model and was apparently dose-independent over an 8-fold dose range. Although a slight dose dependence in the elimination of AG was suggested over a 16-fold dose range, for the purpose of the present study, it was assumed that the disposition of AG is approximately linear. The excretion of AS in the bile was negligibly small, whereas a considerable amount of AG was excreted into the bile. The results following intraduodenal injection of AS or AG indicated that AS or AG was hydrolyzed by the microflora and the liberated acetaminophen was reabsorbed, confirming enterohepatic circulation of the conjugates. This was consistent with the urinary metabolite excretion patterns observed after acetaminophen injection in normal and bile fistula rats. Based on the kinetic parameters obtained, the plasma concentrations of AS and AG after acetaminophen injection were simulated, and a fairly good agreement was obtained between calculated and observed values at the dose of 264.6 mumol/kg. Although the urinary metabolite excretion pattern differs from that of humans, the kinetic parameters obtained for rats were similar to those for humans in some respects, suggesting that the rat might be useful as a model animal to predict human data.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644552     DOI: 10.1007/BF01061867

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  35 in total

1.  Metabolism of a biliary metabolite of phenacetin and other acetanilides by the intestinal microflora.

Authors:  G E Smith; L A Griffiths
Journal:  Experientia       Date:  1976-12-15

2.  Renal tubular transport of paracetamol and its conjugates in the dog.

Authors:  G G Duggin; G H Mudge
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

3.  Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage.

Authors:  M Davis; C J Simmons; N G Harrison; R Williams
Journal:  Q J Med       Date:  1976-04

4.  Paracetamol metabolism in the rat: relationship to covalent binding and hepatic damage.

Authors:  M Davis; N G Harrison; G Ideo; B Portmann; D Labadarios; R William
Journal:  Xenobiotica       Date:  1976-04       Impact factor: 1.908

5.  Effect of aspirin on biotransformation of 14C-acetaminophen in rats.

Authors:  B H Thomas; W Zeitz; B B Coldwell
Journal:  J Pharm Sci       Date:  1974-09       Impact factor: 3.534

6.  Drug absorption, metabolism, and excretion. VII. Pharmacokinetics on formation and excretion of the conjugates of N-acetyl-p-aminophenol in rabbits.

Authors:  J Shibasaki; R Konishi; Y Takeda; T Koizumi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1971-09       Impact factor: 1.645

7.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

8.  Effect of experimental hepatic injury on in vitro drug-metabolizing enzyme activities in the rat.

Authors:  R A Willson; F E Hart
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

9.  Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.

Authors:  R E Galinsky; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

10.  Effect of N-acetylcysteine on the pharmacokinetics of acetaminophen in rats.

Authors:  R E Galinsky; G Levy
Journal:  Life Sci       Date:  1979-08-20       Impact factor: 5.037

View more
  15 in total

1.  The effect of moderate hemodilution with fluosol-DA or normal saline on acetaminophen disposition in the rat.

Authors:  R P Shrewsbury; L G White
Journal:  Experientia       Date:  1990-02-15

2.  Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats.

Authors:  Venkat R Pannala; Kalyan C Vinnakota; Kristopher D Rawls; Shanea K Estes; Tracy P O'Brien; Richard L Printz; Jason A Papin; Jaques Reifman; Masakazu Shiota; Jamey D Young; Anders Wallqvist
Journal:  Toxicol Appl Pharmacol       Date:  2019-04-08       Impact factor: 4.219

3.  Differential regulation of mitogen-activated protein kinase pathways by acetaminophen and its nonhepatotoxic regioisomer 3'-hydroxyacetanilide in TAMH cells.

Authors:  Brendan D Stamper; Theo K Bammler; Richard P Beyer; Frederico M Farin; Sidney D Nelson
Journal:  Toxicol Sci       Date:  2010-04-02       Impact factor: 4.849

4.  Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity.

Authors:  M E Morris; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

5.  Outcomes from massive paracetamol overdose: a retrospective observational study.

Authors:  Daniel J B Marks; Paul I Dargan; John R H Archer; Charlotte L Davies; Alison M Dines; David M Wood; Shaun L Greene
Journal:  Br J Clin Pharmacol       Date:  2017-01-25       Impact factor: 4.335

6.  Proteomic analysis of acetaminophen-induced changes in mitochondrial protein expression using spectral counting.

Authors:  Brendan D Stamper; Isaac Mohar; Terrance J Kavanagh; Sidney D Nelson
Journal:  Chem Res Toxicol       Date:  2011-02-18       Impact factor: 3.739

7.  Time-dependent variations in the organ extraction ratios of acetaminophen in rat.

Authors:  P M Bélanger; M Lalande; F Doré; G Labrecque
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

8.  Quantitation of the pathways of hepatic glycogen formation on ingesting a glucose load.

Authors:  I Magnusson; V Chandramouli; W C Schumann; K Kumaran; J Wahren; B R Landau
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

9.  Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress.

Authors:  S D Studenberg; K L Brouwer
Journal:  J Pharmacokinet Biopharm       Date:  1993-04

Review 10.  Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats.

Authors:  Joost Westerhout; Bart Ploeger; Jean Smeets; Meindert Danhof; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2012-05-17       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.